The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content reports on another lawsuit filed in Vermont against the manufacturers of blood-thinning drug Xarelto. The suit was filed in Vermont federal court under case number 2:14-cv-00159-CR by the daughter of a man who died due to uncontrollable bleeding. The allegations within the suit say that the uncontrollable bleeding and subsequent death was caused by Xarelto.

Case Facts and Atrial Fibrillation

The father was prescribed Xarelto, as many people are, due to his atrial fibrillation. This is a heart condition that can cause complications such as blood clots or strokes, so many individuals with this condition are put on blood thinning drugs preventatively. After using the medication for a short amount of time, the man was injured and hospitalized. There, physicians diagnosed him with a parenchymal hemorrhage. Because the man’s system still contained active Xarelto, however, his hemorrhage was unable to clot. Doctors tried to save the man for 6 days before he ultimately passed away due to the bleed.

In the daughter’s complaint, she notes that had she and her father been made aware that the drug had no antidote, they would never have used it. She indicated that she now realized there were safer alternatives available, and that Xarelto manufacturers Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson) were reckless and negligent by marketing a drug without a corresponding antidote.

Xarelto And Alleged Warning Label Shortcomings

If someone taking Xarelto becomes injured and bleeds, physicians are unable to get their blood to clot, and have to resort to life-saving measures such as blood transfusions in an attempt to keep the patient alive. Traditional blood thinners do not have this problem. The effects of these drugs can be counteracted with vitamin K, causing blood to clot. This means that if someone using traditional blood thinners becomes injured and bleeds, they can be saved more easily.

As Xarelto lawsuits have recently increased in number, they were consolidated to form multidistrict litigation number 2592. It is fully expected that as these cases await trial, others will join them. Attorney Marc Goldich is currently working to ensure that anyone who has suffered adverse health effects after taking Xarelto has the opportunity to explore their legal rights. These individuals may be entitled to compensation. Marc Goldich, Esq. is offering free consultations to those involved..

For information or questions regarding this press release or Xarelto litigation, contact Marc Goldich, Esq.


Comments are closed.